Literature DB >> 15149508

Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.

C A Harwood1, T Surentheran, P Sasieni, C M Proby, C Bordea, I M Leigh, F Wojnarowska, J Breuer, J M McGregor.   

Abstract

BACKGROUND: Human papillomaviruses (HPVs) are found in normal skin and in benign and malignant skin conditions. Epidermodysplasia verruciformis (EV) HPV types are those most plausibly linked to the development of squamous cell carcinomas of the skin.
OBJECTIVES: To assess the risk of nonmelanoma skin cancer (NMSC) associated with the presence of EV HPV in normal skin in immunocompetent (IC) individuals and renal transplant recipients (RTRs).
METHODS: Using a degenerate and nested polymerase chain reaction technique, HPV DNA was sought in 124 normal skin samples from sun-exposed and nonsun-exposed sites, from 39 IC individuals and 38 RTRs, both with and without NMSC. Data were analysed using the Mantel-Haenszel test and by logistic regression analysis.
RESULTS: HPV DNA was detected in 58/67 (87%) and 20/57 (35%) samples from renal transplant and IC patients, respectively. There was no difference in either the prevalence or spectrum of HPV types found in sun-exposed and nonsun-exposed normal skin. However, there was significant association between NMSC and the presence of EV HPV DNA. Multivariate analysis provided an odds ratio of 6.41 (95% confidence interval 1.79-22.9) for the association of EV HPV DNA in normal skin (irrespective of site) and NMSC status, even after stratifying for patient group and adjusting for the clustering effect of multiple sampling. Conversely, there was no association between skin cancer status and the presence of cutaneous or mucosal HPV types in either sun-exposed or nonsun-exposed skin.
CONCLUSIONS: HPV DNA is widespread in normal adult skin, particularly in transplant patients. In our study, the presence of EV but not cutaneous HPV DNA in normal skin was significantly associated with NMSC status and may prove to be of predictive value for skin cancer risk. These data provide reason to focus on EV HPV types as causal agents in skin cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149508     DOI: 10.1111/j.1365-2133.2004.05847.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  29 in total

1.  E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.

Authors:  Angelika Michel; Annette Kopp-Schneider; Hanswalter Zentgraf; Achim D Gruber; Ethel-Michele de Villiers
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  Quantification of beta-human papillomavirus DNA by real-time PCR.

Authors:  Sönke J Weissenborn; Ulrike Wieland; Monika Junk; Herbert Pfister
Journal:  Nat Protoc       Date:  2010-01       Impact factor: 13.491

3.  HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.

Authors:  Michael J Silverberg; Wendy Leyden; E Margaret Warton; Charles P Quesenberry; Eric A Engels; Maryam M Asgari
Journal:  J Natl Cancer Inst       Date:  2013-01-04       Impact factor: 13.506

Review 4.  DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.

Authors:  Nicholas D Weber; Martine Aubert; Chung H Dang; Daniel Stone; Keith R Jerome
Journal:  Virology       Date:  2014-01-31       Impact factor: 3.616

Review 5.  An Emerging Issue in Oncogenic Virology: the Role of Beta Human Papillomavirus Types in the Development of Cutaneous Squamous Cell Carcinoma.

Authors:  Dana E Rollison; Daniele Viarisio; Rossybelle P Amorrortu; Tarik Gheit; Massimo Tommasino
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

6.  Determination of the relationship between Basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method.

Authors:  M Mokhtari; A Mesbah; P Rajabi; M Ail Rajabi; A Chehrei; K Mougouei
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

Review 7.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

8.  Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.

Authors:  Alessandra Handisurya; Ratish Gambhira; Christina Schellenbacher; Saeed Shafti-Keramat; Ola Forslund; Michel Favre; Reinhard Kirnbauer
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

9.  Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs.

Authors:  Karin J Purdie; Catherine A Harwood; Abha Gulati; Tracy Chaplin; Sally R Lambert; Rino Cerio; Gavin P Kelly; Jean-Baptiste Cazier; Bryan D Young; Irene M Leigh; Charlotte M Proby
Journal:  J Invest Dermatol       Date:  2009-01-08       Impact factor: 8.551

Review 10.  Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?

Authors:  Bishr Aldabagh; Jorge Gil C Angeles; Adela R Cardones; Sarah T Arron
Journal:  Dermatol Surg       Date:  2012-08-28       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.